MétaCan
Menu
Back to cohort
Record W4397041787 · doi:10.1681/asn.20233411s11033a

Effect of Prolonged-Release vs. Immediate-Release Tacrolimus on Neurocognition in Kidney Transplant Recipients: A Pilot Randomized Controlled Trial (RCT)

2023· article· en· W4397041787 on OpenAlexaboutno aff
Hadia Lala Gul, Macey Sockolov, Amanpreet Kaur, Michelle Occhipinti, Heejung Bang, Muna Alnimri, Yihung Huang, Lingxin Chen, Katherine A. Howes

Bibliographic record

VenueJournal of the American Society of Nephrology · 2023
Typearticle
Languageen
FieldMedicine
TopicNeurological Complications and Syndromes
Canadian institutionsnot available
Fundersnot available
KeywordsRandomized controlled trialTacrolimusMedicineKidney transplantInternal medicineKidney transplantationKidneyTransplantation

Abstract

fetched live from OpenAlex

Background: Tacrolimus is known to cause neurological side effects and elderly individuals seem particularly vulnerable. It is unknown if the prolonged-release (PR) tacrolimus (Envarsus XR) formulation minimizes neurocognitive side effects compared to immediate release (IR) tacrolimus due to lower peak serum levels. We aimed to compare the neurocognitive side effects of PR and IR tacrolimus in elderly kidney transplant recipients within the first months post-transplantation. Methods: In this single center, prospective, open-label, randomized trial, 64 kidney transplant recipients aged 60 or above were randomized to PR tacrolimus or IR tacrolimus between 4 and 8 weeks post-transplantation and followed for 6 weeks. Neurocognitive performance was assessed by the Montreal Cognitive Assessment (MOCA) and Digit Symbol Substitution Test (DSST). Secondary outcomes of tremor and quality of life were assessed through the Quality of Life in Essential Tremor Questionnaire (QUEST) and Organ Transplant Symptom and Wellbeing Instrument (OTSWI). Results: 32 patients were randomized to the IR tacrolimus arm and 31 into the PR tacrolimus arm. Mean age was 69 in both arms and 37% were women. Table 1 shows the assessment scores for the primary and secondary outcomes. There was no statistically significant difference between groups in the change in MOCA or DSST scores from baseline to 6 weeks or in tremor or quality of life measures. Table 1. - Neurocognitive Testing and Tremor Results.P-values were computed from ANCOVA adjusting baseline value and without adjusting for multiplicity. Values shown are mean and (standard deviation). IR Tacrolimus (n=32) ER Tacrolimus (n= 31) p Primary Outcomes Baseline MOCA score 23 (3.8) 22 (5.3) Baseline corrected MOCA score 23.3 (3.7) 22 (7) 6-week MOCA score 22.8 (7) 22 (6.3) 6-week corrected MOCA score 24.7 (3.6) 23 (5) MOCA (corrected) score difference 1.2 (2.1) 0.2 (2.9) 0.06 Baseline DSST score 35.1 (13) 32.5 (14) 6-week DSST score 35.7 (11.5) 34.3 (16) DSST score difference 1.0 (7.8) 1.26 (7.5) 0.96 Secondary Outcomes Baseline Quest Summary Score 8.2 (14.4) 7.7 (12.3) 6-week Quest Summary Score 7.4 (11.4) 4.3 (5.8) Quest Summary Score difference -1.0 (10.4) -2.9 (10.0) 0.15 Baseline OTSWI 25.5 (18.3) 25 (18) 6 Week OTSWI 23.5 (19.2) 19 (13) OTSWI Score difference -2.1 (9.7) -6.2 (12.0) 0.1 Conclusions: Although prior studies indicated improvement in neurological side effects in PR tacrolimus compared with IR tacrolimus, the improvement does not appear to extend to neurocognitive side effects as assessed by the MOCA or DSST tests in this cohort. Funding: Commercial Support - Veloxis Pharmaceuticals, Inc

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.002
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Randomized trial · Consensus signal: Randomized trial
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.035
Threshold uncertainty score0.471

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0020.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0030.002
Bibliometrics0.0000.001
Science and technology studies0.0000.001
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.017
GPT teacher head0.290
Teacher spread0.274 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designRandomized trial
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2023
Admission routes1
Has abstractyes

Explore more

Same venueJournal of the American Society of NephrologySame topicNeurological Complications and SyndromesFrench-language works237,207